Abstract
Background
Back pain has a high global prevalence and carries a substantial risk for chronification. Biopsychosocial factors are assumed to be critical in the transition from acute to chronic back pain. Digital interventions are a promising tool to educate patients about their complaints. Thus, providing patients with an explanatory model regarding their individual risk factors in the early stage of their complaints via the internet might thus be a valuable approach in treatment.
Objectives
The objectives of the present online study are to investigate the influence of a personalized psychoeducational intervention on self-efficacy and functioning and to examine biopsychosocial risk factors for symptom chronification. The intervention is based on a current model summarizing the empirical knowledge on relevant factors for persistent somatic symptoms, which has not been studied in back pain patients yet.
Methods
An observational cohort of patients with acute and subacute back pain (N = 564) will be asked about biopsychosocial risk factors via online survey at baseline, 4-week, and 12-week follow-up. Within this cohort, a randomly selected group of 132 participants (intervention group) with psychological burden (MCS-12 score of the SF-12 ≤ 50) and relevant somatic symptom intensity and interference (mean sum score of two numeric rating scales ≥5) and no prior psychotherapeutic treatment will be offered a personalized explanatory model in the form of an animated psychoeducational video. The video will be personalized in terms of participants' individual symptom profile and will be made accessible to watch online for 7 days. Participants will be compared to a control group receiving no treatment regarding change in pain-specific self-efficacy after 1 month as primary outcome, and change in functioning after 1 and 3 months, respectively, as secondary outcomes. Acceptance and usefulness of the intervention will be evaluated using the number of video views and a numeric rating scale.
Discussion
This is the first investigation of a personalized, video-animated online psychoeducation based on patients' individual risk factors for the chronification of back pain and the first systematic evaluation of the risk factors included in a comprehensive aetiological model on persistent somatic symptoms in back pain patients. This way, this study contributes to the understanding of cross-disorder psychopathological factors and a stronger consideration of biopsychosocial factors in the treatment of persistent somatic symptoms. If proven effective, the internet-based intervention will make an important contribution to the early treatment of back pain.
Ethical approval
The study was approved by the Local Psychological Ethics Committee (LPEK) at the Center for Psychosocial Medicine of the University Medical Center Hamburg-Eppendorf.
Trial registration
The study was registered at the German Clinical Trials Register in December 2021 (registration trial number: DRKS00025445).
Keywords: Back pain, Persistent somatic symptoms, Biopsychosocial risk factors, Self-efficacy, Psychoeducation, Online intervention
Highlights
-
•
Evaluation of an aetiological model on persistent somatic symptoms in back pain
-
•
Animated psychoeducation on back pain chronification based on individual risk factors
-
•
Promising approach to enhance self-efficacy, counteracting symptom chronification
-
•
Feasible, convenient, cost-effective online intervention
-
•
Intervention can for example be used as part of a stepped-care program
1. Introduction
Back pain is one of the most common medical symptoms worldwide, resulting in substantial patient impairment as well as excessive costs for the healthcare system (World Health Organization, 2021). A recent cross-sectional survey shows that 61.3 % of the German population suffered from back pain within the last 12 months (von der Lippe et al., 2020). Although back pain often takes a favorable course, a significant proportion of patients develop chronic back pain (Costa et al., 2012). Despite these facts, many patients do not receive treatment concordant with current guidelines (Stevans et al., 2021). For instance, a central element in back pain management according to national and international guidelines is to provide information on health-conscious behavior and to convey a biopsychosocial model early in the treatment process (National Guideline Centre UK, 2016; Bundesärztekammer (BÄK), 2017). Studies have shown, though, that this is often impeded not only due to patients', but also healthcare professionals' biomedical focuses and beliefs (Darlow et al., 2012).
Research in the past decades has demonstrated that psychological and psychosocial risk factors are consistently more crucial for the chronification of back pain than biomedical risk factors (Vargas-Prada and Coggon, 2015). In a systematic review, Chou and Shekelle (2010) identified maladaptive pain coping behaviors, non-organic signs (defined as psychological components or intentionally misreported or exaggerated symptoms (Waddell et al., 1980)), functional impairment, general health status, and comorbid psychological disorders as the strongest predictors of chronic back pain, accordingly.
However, there is still little consensus regarding the cross-disorder aetiology of persistent somatic symptoms (PSS), including chronic back pain, in general. Current aetiological models assume that biopsychosocial risk factors contribute to the chronification of somatic symptoms and that higher-level mechanisms of action are valid regardless of the “explainability” of complaints from an organ pathological perspective (Klaus et al., 2013). A recently published comprehensive vulnerability-stress model summarizes the current evidence regarding predisposing, triggering, and maintaining factors in the transition from acute symptoms to PSS (Henningsen et al., 2018). As a result, a variety of potentially relevant factors have been identified that may influence patients' perceptions of their somatic symptoms. At the same time, these factors are thought to affect the intensity of symptoms, expectations regarding symptom development, as well as the constellation in which biopsychosocial factors influence the course of somatic symptoms (Deary et al., 2007; Rief and Martin, 2014). In a large German research unit (SOMACROSS (Löwe et al., 2022)), the model provides the basis for developing a deeper disorder-specific understanding of psychopathological risk factors across different medical disciplines, while identifying higher-level mechanisms and exploring opportunities for change. Despite the great relevance of chronic back pain within the field of PSS, the model has not yet been specifically studied in this patient group.
One key mechanism regarding the experience of pain and disability is patients' pain-related self-efficacy (Woby et al., 2007). It has been found to be even more relevant than fear of movement (Costa et al., 2011). According to current research and clinical practice, promoting patients' self-efficacy with regard to their symptoms is the primary goal in therapy, providing the best positive long-term effects (Schiltenwolf and Henningsen, 2018). There are different approaches to promote patients' self-efficacy within a biopsychosocial framework. A central element of cognitive behavioral therapy (CBT), which has been well studied for its efficacy in chronic back pain (Kröner-Herwig, 2018), is the development of an individual explanatory model. In CBT, the conveyance of disorder-specific information with the aim of empowering patients and promoting self-efficacy is often summarized under the term psychoeducation. A Cochrane review showed that an average of 2.5 h of psychoeducation was sufficient to improve the treatment outcome of subacute back pain and to enable an earlier return to work (Engers et al., 2008).
In the same study, the authors noted that the way psychoeducation was delivered could have a strong influence on effectiveness, and further criticized that none of the included studies had specified which theoretical model the psychoeducation was based on (Engers et al., 2008). It therefore seems conceivable that shorter interventions might also be beneficial to back pain patients if they are theory-based and delivered in a user-oriented way, e.g., by using digital media. In a recently published study, for instance, a brief psychoeducational intervention has shown significant symptom improvement in somatic symptom disorder (Johnson et al., 2022). Notably, internet-based interventions have several advantages: Besides being easy to deliver and administer, they are convenient for users, cost-effective, scalable, and provide the ability to personalize content to meet individual needs (Borrelli and Ritterband, 2015). Technology-based interventions have been shown to positively affect PSS including chronic pain (Vugts et al., 2018). At the same time, content quality of public back pain websites or videos on streaming platforms like YouTube has been found to be low (Costa et al., 2020; Hornung et al., 2022). Accordingly, there is a need for higher quality information on back pain on the internet.
Experimental studies and evidence-based recommendations on health communication point out that the information provided should meet personal needs (Hollands and Marteau, 2013), be presented in lay language (Lühnen et al., 2015), and allow patients an active choice in content selection (Kreuter and Wray, 2003). Even though such a personalized approach has been recommended for digital interventions (O'Connor et al., 2016), tailoring is often not implemented in interventions for back pain (Nicholl et al., 2017).
In summary, back pain patients are oftentimes not provided with biopsychosocial psychoeducation in order to prevent chronification and foster patients' self-efficacy. The biopsychosocial risk factors of a current evidence-based aetiological model on PSS have not yet been studied in chronic back pain. Existing psychoeducational interventions often lack both a theoretical foundation as well as individual tailoring in terms of symptomatology. Since internet-based interventions are a promising tool for patient education, we assume that a patient-oriented conveyance of personalized psychoeducation on back pain via the internet can increase self-efficacy of those affected and consequently prevent chronification (see Fig. 1). In this study, we thus want to assess the influence of a video-animated psychoeducation on patients' pain-related self-efficacy by developing animated videos that help patients to understand contributing factors regarding their back pain, and show ways to improve behavioral, cognitive, and affective components. This effect will be further strengthened by elements of personalization, i.e., the selection of those components that are relevant to the patient, rather than generally applicable, based on the patient's individual symptom score with regard to a predefined selection of potential risk factors for the chronification of back pain. In addition, we will examine the effect of the personalized psychoeducation on functioning as well as investigate further biopsychosocial risk factors for the development and maintenance of chronic back pain according to a current aetiological model. To the best of our knowledge, no online study to date has examined the effect of individualized psychoeducation on self-efficacy and functioning in back pain patients.
Fig. 1.
Schematic illustration of the hypothesized mechanisms of action of conveying a personalized psychoeducation to back pain patients, based on the working model of the research unit SOMACROSS (Löwe et al., 2022).
1.1. Objectives
The primary aim of the IDRIS study (full title: From the identification of biopsychosocial risk factors to an increase in pain-related self-efficacy – The online-based conveyance of an explanatory model for chronic back pain) is to examine if patients' pain-related self-efficacy can be altered by the presentation of a personalized, animated psychoeducational online intervention at the early stage of symptoms. Second, it will assess the effect of the intervention on functioning. In addition, the study will investigate the biopsychosocial risk factors of an evidence-based aetiological model for the development and maintenance of chronic back pain.
2. Methods and analysis
2.1. Study design
The IDRIS trial is designed as an internet-based study on patients with acute and subacute back pain, which will be conducted nationwide in Germany. According to the “cohort multiple randomized controlled trial” design (Relton et al., 2010), a total observational cohort of patients in the early phase of their complaints (duration ≤ 12 weeks) will be collected. At baseline (T0), 4-week (T1), and 12-week (T2) follow-up, patients will be asked about biopsychosocial risk factors with regard to a possible chronification of their complaints via an online survey using the software REDCap (Harris et al., 2019). Subsequently, an explorative comparison of the severity of risk factors in those patients with and without chronic back pain will be carried out. From the total cohort, a group of eligible study participants will be randomly selected and offered a personalized psychoeducation to evaluate the influence of a personalized explanatory intervention on pain-related self-efficacy and on functioning (randomized controlled trial cohort). The term personalized refers to the inclusion of only those risk factors in each participant's intervention video that are relevant to that individual person. Accordingly, the selection of videos to create a personalized intervention for participants will be based on the individual data collected at T0. Participants will receive a link to access their personalized animation video for 7 days. The intervention group will then be compared with a randomly selected eligible control group, with respect to the primary and secondary outcomes. Data collection and management will be in accordance with the European General Data Protection Regulation as well as German law.
2.2. Study procedures
2.2.1. Recruitment
The complete study will be conducted online. N = 564 participants will be recruited from the general population via the internet, i.e., social media, internet forums, and professional associations, as well as in specific therapeutic settings, e.g., physiotherapy practices. All recruitment ways will lead to an open access study website, which contains detailed information on the study, data safety procedures, the study team, and contact information. Interested applicants will be asked to provide online informed consent and to complete the T0 assessment thereafter.
2.2.2. Inclusion and exclusion criteria
We will include participants aged between 18 and 67 years who have been suffering from back pain for a maximum of 12 weeks. Exclusion criteria are chronic back pain (duration >12 weeks), a severe acute somatic back injury (herniated disc, surgical intervention, etc.), insufficient knowledge of the German language, a self-reported substance use disorder, and insufficient self-reported mental or physical health for study participation.
Explicit inclusion criteria for participation in the randomized controlled trial (RCT) cohort are a minimum burden due to psychological distress operationalized as score of ≤50 in the Mental Composite Scale (MCS-12) of the Short Form 12 (SF-12) (Ware et al., 1996) and a minimum burden in terms of symptom intensity and symptom interference corresponding to a mean sum score of ≥5 on two numerical rating scales (NRS; range: 0–10) (Rief et al., 2017). The MCS-12 score of ≤50 was chosen as it is the general population mean (Ware et al., 1996) and has been recommended as a screening cut-off for mental disorders (Gill et al., 2007). For chronic pain patients, scores between 34 (Díaz-Arribas et al., 2017) and 40 (Piontek et al., 2019) have been found, but due to our target population of patients in the early phase of their complaints, a liberal inclusion criterion seemed appropriate. Explicit exclusion criteria for participation in the RCT cohort are a current or previous inpatient psychosomatic hospital or rehabilitation treatment and a current or previous outpatient psychotherapy due to back pain. Eligibility criteria will be assessed within a self-report online survey at T0.
2.2.3. Randomization
All included participants from the total cohort (N = 564) will be screened to determine if they meet the criteria for the RCT cohort. Eligible participants included in the RCT cohort will be randomly assigned to either the intervention or the control group. Randomization within the RCT cohort will take place directly after inclusion, based on a random number system and a web-based randomization tool. According to the sample size/power calculation, n = 264 participants who meet the inclusion criteria for the RCT cohort are required. Fig. 2 provides a detailed overview of the study flow.
Fig. 2.
Flow chart of the IDRIS study.
2.3. Variables and instruments
All participants will complete online questionnaires on potential risk factors for the chronification of back pain at baseline, 4-week, and 12-week follow-up. An overview of all instruments employed at baseline and follow-up is provided in Table 1.
Table 1.
Overview of instruments employed in the IDRIS study.
| Risk factors and mechanisms (assessed via self-report) | ||||||
|---|---|---|---|---|---|---|
| Predisposing, triggering, and maintaining/aggravating factors | Single constructs | Instrument | Items | Months |
||
| 0 | 1 | 3 | ||||
| Sociodemographic factors | Gender, age, nationality, height, weight, marital status, migration status, current housing situation, insurance, education, occupational status, smoking | Single items | 20 | X | ||
| Health care utilization | Single items | 2 | X | X | X | |
| SARS-CoV-2 infection and Long COVID | Single items | 7 | X | X | X | |
| Psychosocial factors | (Complex) PTSD | International Trauma Questionnaire (ITQ) | 18 | X | ||
| Negative affectivity | Positive and Negative Affectivity Schedule (PANAS) | 20 | X | |||
| Life stressors | Perceived Stress Scale (PSS-10) | 10 | X | |||
| Perceived stigmatization | Single items | 2 | X | |||
| Cognitive-perceptual and emotional mechanisms | Somatosensory amplification | Somatosensory Amplification Scale (SSAS) | 10 | X | X | X |
| Catastrophizing | Coping Strategies Questionnaire - Catastrophizing Subscale (CSQ-CAT) | 6 | X | X | X | |
| Treatment expectations | Treatment Expectation Questionnaire (TEX-Q) | 17 | X | X | X | |
| Expectation of symptom severity | Numeric Rating Scale | 1 | X | X | X | |
| Expectation of symptom burden | Numeric Rating Scale | 1 | X | X | X | |
| Expectation of coping with symptoms | Numeric Rating Scale | 1 | X | X | X | |
| Illness-related worries | Whiteley-Index Short Version (WI-7) | 7 | X | X | X | |
| Symptom perception | Illness perception questionnaire (B-IPQ) | 8 | X | X | X | |
| Anxiety severity | Generalized Anxiety Disorder-7 (GAD-7) | 7 | X | X | X | |
| Depression severity | Patient Health Questionnaire-8 (PHQ-8) | 8 | X | X | X | |
| Alexithymia | Toronto Alexithymia Scale (TAS-20) | 20 | X | |||
| Emotion regulation | Emotion Regulation Questionnaire (ERQ) | 10 | X | |||
| COVID-19 anxiety | Single item | 1 | X | X | X | |
| Behavioral factors | Physical inactivity | International Physical Activity Questionnaire (IPAQ-SF) | 7 | X | X | X |
| Pain avoidance/endurance | Avoidance-Endurance Fast Screening (AE-FS) | 9 | X | X | X | |
| Fear of movement | Tampa Scale for Kinesiophobia (TSK-GV) | 11 | X | X | X | |
| Biomedical and treatment-related factors | (Prior) organic disease/comorbidity | Self-Administered Comorbidity Questionnaire (SCQ) | 16 | X | X | |
| Medication adherence | Medication Adherence Report Scale (MARS-D) | 5 | X | X | X | |
| Treatment side effects | Numeric Rating Scale | 1 | X | X | X | |
| Treatment experience | Numeric Rating Scale | 2 | X | X | X | |
| Symptom duration | Single item | 1 | X | |||
| Pain severity | Classification of von Korff et al. | 8 | X | X | ||
| Medication | Single item | 2 | X | X | ||
| Somatic symptom burden | Patient Health Questionnaire (PHQ-15) | 15 | X | X | X | |
| Outcome variables (assessed via self-report) | ||||||
| Primary outcome: self-efficacy | Self-efficacy | Fragebogen zur Erfassung der schmerzspezifischen Selbstwirksamkeit (FESS) | 10 | X | X | X |
| Secondary outcomes: functioning | Symptom intensity | EURONET-SOMA Numeric Rating Scale | 1 | X | X | X |
| Symptom interference | EURONET-SOMA Numeric Rating Scale | 1 | X | X | X | |
| Symptom-related disability | Pain Disability Index – adapted (PDI) | 7 | X | X | X | |
| Health-related quality of life | Short Form Health Survey (SF-12) | 12 | X | X | X | |
| Acceptance and usefulness of the intervention (RCT cohort only) |
Use of the individualized video | Number of video views within 7 days | N/A | X | ||
| Perceived usefulness of the intervention | Numeric Rating Scale | 5 | X | |||
| TOTAL (self-report items) | 289 | |||||
2.3.1. Self-efficacy and functioning
The primary outcome of the RCT will be change in patients' pain-specific self-efficacy after 1 month, determined via the German adaptation of the Pain Self-Efficacy Questionnaire (“Fragebogen zur Erfassung der schmerzspezifischen Selbstwirksamkeit”; ∆FESS) (Mangels et al., 2009). Secondary outcomes will be change in functioning after 1 and 3 months. Symptom intensity and symptom interference will be assessed using two numerical rating scales according to the recommendations of EURONET-SOMA (Rief et al., 2017). Symptom-related disability will be measured using an adapted version of the Pain Disability Index (Dillmann et al., 1994) and health-related quality of life using the SF-12 (Ware et al., 1996). Further variables included in the study are summarized in Table 1. Further information on the corresponding instruments can be found in the study protocol of SOMACROSS (Löwe et al., 2022).
2.3.2. Acceptance and usefulness of the intervention
The total number of video views within the 7 days will be used to quantitatively estimate acceptance and feasibility of the intervention. Perceived usefulness of the intervention will be measured using five NRS (range: 0–10).
2.3.3. Sample characterization
In order to describe the study sample, sociodemographic information on age, gender, nationality, martial status, living situation, insurance, education, occupational status, healthcare utilization, smoking, weight, height, and data on symptom onset, pain intensity, and medication will be collected online via self-report at T0. Data will also include somatic and mental comorbidities: Depression will be measured using the Patient Health Questionnaire (PHQ-8) (Löwe et al., 2004), anxiety via the Generalized Anxiety Disorder Scale 7 (GAD-7) (Spitzer et al., 2006).
2.4. Intervention group
The personalized and visualized psychoeducation will be made available for the intervention group immediately after randomization. After receiving a link to access their personalized animated video, participants will be able to watch the video for 7 days on any digital device (computer, tablet, smartphone, etc.). Participants will be informed that the video has been created based on their own data entries and is tailored to their individual symptom profile. They will further be informed that the video includes information on factors influencing their back pain and on how to potentially address these factors. In order to benefit the most from all the information provided, participants will be advised to watch their personalized video several times, e.g., once a day. Length of the intervention will depend on the number of factors identified to be relevant for the individual participant.
2.4.1. Development and design of the intervention
The intervention development and implementation consists of three sub-steps. In the first step, animated short films will be created for a total of eight selected risk factors which have been identified in the literature as particularly relevant for the chronification of back pain and which can also be operationalized as elements of the aetiological model by Henningsen et al. (2018), using the software Adobe After Effects 2022 (version 22.1.1) (Adobe After Effects, 2022). The videos will be made explicitly for the patient target population, using lay language and compromised information from research findings. Besides information on biopsychosocial factors, potential for change will be illustrated in order to promote an increase in self-efficacy. In the second step, those risk factors that are relevant for the individual patient will be determined algorithmically by means of questionnaires, using cut-off scores at baseline. Thus, if a patient's baseline questionnaire score reaches a predefined cut-off, the risk factor assessed by the questionnaire is considered to be relevant to the patient so that he/she will receive the corresponding animated short film on that factor as part of his/her individual psychoeducation. For an overview of the eight risk factors potentially addressed in the intervention, core elements of the intervention modules, as well as corresponding questionnaires and cut-off scores see Table 2. Out of each short film, one complete personalized film will be compiled for each participant in the intervention group in the third step. This film will be sent to the patient via a link and made available online for 7 days.
Table 2.
Risk factors for the chronification of back pain potentially addressed in the intervention based on cut-off scores in the corresponding questionnaires and core elements of the intervention modules.
| Risk factor | Instrument | Cut-off score | Core elements of the intervention module |
|---|---|---|---|
| Depression severity | PHQ-8 | ≥5 |
|
| Health anxiety | WI-7 | ≥2 |
|
| Catastrophizing | CSQ-CAT | ≥10 |
|
| Pain endurance | AE-FS | PPS subscale ≥3 |
|
| Fear of movement and physical inactivity | TSK-GV | ≥25 |
|
| IPAQ-SF | ≤Moderate physical activity | ||
| Symptom and treatment expectations | TEX-Q | Positive expectations ≤6 |
|
| Negative expectations ≥5 | |||
| NRS (EXPECT 1, 2, 3) | Mean score ≥ 5 | ||
| Traumatic experiences | ITQ | ≥13 |
|
| Emotion regulation deficits | ERQ | Reappraisal ≤4.0 |
|
| Suppression ≥3.5 |
Note. PHQ-8 = Patient Health Questionnaire-8, WI-7 = Whiteley-Index Short Version, CSQ-CAT = Coping Strategies Questionnaire - Subscale, AE-FS = Avoidance-Endurance Fast Screening, TSK-GV = Tampa Scale for Kinesiophobia, IPAQ-SF = International Physical Activity Questionnaire, TEX-Q = Treatment Expectation Questionnaire, NRS = Numeric Rating Scale, ITQ = International Trauma Questionnaire, ERQ = Emotion Regulation Questionnaire.
2.4.2. Control group
Participants in the control condition will receive no animated psychoeducation. Their data will be used for comparison with the intervention group.
2.5. Sample size/power calculation
An explorative approach was chosen for the identification of risk factors within the total study cohort. The RCT is powered with regard to the difference in change of pain-related self-efficacy between the intervention and the control group as effect of the intervention, thus forming our primary objective. As the intervention to be tested is a brief intervention in the initial stage of symptoms in untreated patients and based on previous findings (Nicholl et al., 2017), we assume a small effect f = .15 (Cohen, 2013). We further assume a correlation of r = 0.5 between the primary outcome of change in self-efficacy (∆ FESS) and fear of movement (∆ TSK-GV). Fear of movement will be included as a covariate in the design, allowing for a magnification of the expected effect to f = .173 (Lipsey, 1990). To be able to detect this effect size with a two-group analysis of covariance (F-test) and a covariate with α = 0.05 and power = 1-β = 0.8, a sample size of n = 132 in each the intervention and control group is required. The sample size calculation was performed using G*Power (Faul et al., 2009).
Based on our recent experience with another online-based study for patients with depression (Sikorski et al., 2021), we assume an estimated dropout rate of 35 %. Based on data from our outpatient clinic and surveys in the general population (Toussaint et al., 2020), we estimate that a majority (80 %) will meet the specific inclusion criteria in addition to the general ones. Of the eligible participants randomized to the intervention, a majority (90 %) are assumed to participate due to the small amount of additional effort (namely, clicking on a video link and watching the video). This results in a targeted total number of participants of N = 564. In order to reach this number, strategies for recruitment optimization will be applied (Darmawan et al., 2020) and incentives of 20 EUR per participant will be paid.
2.6. Handling of missing values
In case of missing data at either baseline or follow-up, cases will be analyzed according to intention-to-treat principles if a minimum of 75 % of data is present. Participants with ≥25 % missing baseline scores will not be included in the study. To reduce missing data, online questionnaires will check for completeness before submitting. If patients do not respond to the email invitation or the link to the intervention, they will be registered as dropouts after at least 5 attempts of being reached via email reminders. Systematic differences between participants and dropouts will be examined using the provided data.
2.7. Statistical analyses
Since normal distribution can be assumed for sum scores of self-efficacy and functioning, mean score and standard deviation will be used as descriptive characteristic. To test the primary hypothesis (psychoeducational intervention improving pain-related self-efficacy), an ANCOVA with experimental group (personalized psychoeducation vs. no psychoeducation) as independent variable and change in self-efficacy at 1-month follow-up as dependent variable (∆FESS) will be employed, with covariates age, gender, change in fear of movement, and self-efficacy at baseline. For the second hypothesis (the psychoeducational intervention reduces functional impairment), an ANCOVA with experimental group (personalized psychoeducation vs. no psychoeducation) as independent variable and change in functioning at 1- and 3-month follow-up as dependent variables will be employed, with covariates age, gender, and functioning at baseline. For evaluation of the third hypothesis, namely the influence of risk factors on the persistence of back pain, linear regression analyses will be conducted. Results will be reported using regression coefficients corresponding 95-%-confidence intervals and p-values. Statistical analyses will be performed using IMB SPSS Version 27.
2.8. Methods to reduce bias
Selection bias is minimized by the inclusion of a control group and the use of a web-based randomization tool. Presentation of the intervention will be standardized by the use of online videos. The videos on each risk factor will be created with the attempt to maximize comparability in terms of length, amount of content, and visual representation. In order to potentially identify invalid entries, the first online survey will comprise the following two questions as validity checks: “Are you participating in the study seriously?” and “Have you already participated in this study?”. The full recruitment process will be documented according to CONSORT reporting standards (Moher et al., 2012).
2.9. Study registration
The study was registered at the German Clinical Trials Register (Deutsches Register Klinischer Studien (DRKS), registration trial number DRKS00025445), and thereby automatically submitted to the World Health Organization International Clinical Trials Registry Platform.
3. Discussion
The aim of the IDRIS study is to investigate if patients' pain-related self-efficacy can be modified by means of a personalized and visualized internet-based psychoeducation. Additionally, the influence of the personalized psychoeducation on core symptoms as well as the empirical value of biopsychosocial risk factors of a current aetiological model for the development of PSS in patients with back pain will be examined. The animated conveyance of a personalized psychoeducation based on individually meaningful factors is hypothesized to improve pain-related self-efficacy at 1-month follow up as well as to reduce functional impairment at 1-month and 3-month follow-up compared to a control group. It is further hypothesized that biological, psychological, and social factors contribute to the chronification of back pain (duration >12 weeks).
To our knowledge, this study is the first systematic evaluation of the risk factors of the aetiological model by Henningsen et al. (2018) on PSS in patients with back pain. It is also the first personalized approach to employ a video-animated online psychoeducation developed specifically for this patient population. Enhancing self-efficacy by conveying a personalized explanatory intervention based on patients' individual risk factors is a promising approach to counteract a possible chronification of back pain at an early stage. Previous work has already shown that the early conveyance of patient-oriented explanatory models is positively accepted by patients and can improve processes with regard to expectations and communication (Hüsing et al., 2021). Despite the high relevance of back pain for the healthcare sector and guideline recommendations to provide patients with a biopsychosocial model, online or traditional face-to-face psychoeducation of those affected has so far often neither been theory-based nor personalized with respect to the consideration of individual risk factors (Engers et al., 2008; Nicholl et al., 2017).
3.1. Strengths and limitations
Despite the presented possible benefits of the planned study, several limitations have to be considered. The intervention will not address all potential risk factors for the chronification of back pain, but will be focused on psychological (and not, for example, sociological) factors with the most empirical evidence found in the literature. In order to enhance self-efficacy, a special emphasis will be placed on modifiable factors that can be assessed by means of questionnaires. The mere use of self-report instruments is another limitation. Medical aspects (e.g., previous examinations and diagnostic procedures) will thus only be collected through information provided by the participants and will not additionally be verified by physicians' reports or patient records. The personalization of the intervention is limited to the incorporation of individual symptom profiles and does not include, for instance, further aspects of personalization such as participant names or other personal information. This could be a next step in future studies. The deployment of an online intervention might also be a barrier for some patients. However, internet-based tools are becoming more common in the treatment of back pain (Vugts et al., 2018; Nicholl et al., 2017) and offer various benefits (Borrelli and Ritterband, 2015) that also apply to the IDRIS trial. Beyond that, in view of the COVID-19 pandemic and possible future pandemics, the empirical investigation of digital therapeutic applications has a special relevance. Thus, the planned intervention is intended as complementary to other, multimodal therapeutic approaches that are often difficult to access for non-chronic back pain patients. If proven effective, it will make an important contribution to the early treatment of back pain. Overall, the IDRIS study is a well-designed trial based on the combination of clinical and scientific expertise as well as current empirical evidence on biopsychosocial factors in back pain.
3.2. Conclusion
This study contributes to the understanding of evidence-based and cross-disorder psychopathological factors and complies with the current trend towards a stronger consideration of biopsychosocial factors in the treatment of PSS (Gureje, 2015). By testing the effectiveness of an economic and decentralizable mechanism-based online intervention, we strive to make a contribution to changing patients' and healthcare professionals' biomedical beliefs (Darlow et al., 2012). The feasible, convenient, and cost-effective online intervention can for example be used as part of a stepped-care program.
Funding
This work was funded by the Stiftung Psychosomatik der Wirbelsäulenerkrankungen (Principal Investigators: Paul Hüsing, Bernd Löwe).
Ethics and dissemination
The study procedure was reviewed and approved by the Local Psychological Ethics Committee (LPEK) at the Center for Psychosocial Medicine of the University Medical Center Hamburg-Eppendorf (approved on December 9th, 2021; LPEK-0393). Results from this study will be published in peer-reviewed journals and presented at national and international conferences. Before participation, patients will receive detailed information about the nature, purpose, and possible consequences of the trial. Participants will be required to give written informed consent to participate in the study.
Data sharing statement
Individual participant data will be shared and include data that underlie the results reported in this article after deidentification (text, tables, figures, and appendices). Further, the study protocol will be published and made available publicly. Data will be made available 3 months after publication and end 5 years following article publication.
CRediT authorship contribution statement
PH and BL developed the concept and design of the study, and have acquired the funding. PE wrote the draft of this manuscript, PH and BL provided revisions. All authors contributed to the further writing and approved the final version of the manuscript.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Data availability
Data will be shared with researchers who provide a methodologically sound proposal; proposals should be directed to p.huesing@uke.de. To gain access, data requestors will need to sign a data access agreement. Data are available for 5 years at a third party website (https://data.mendeley.com/).
References
- Adobe After Effects [program] 2022. 22.1.1 version: Adobe. [Google Scholar]
- Borrelli B., Ritterband L.M. Special issue on eHealth and mHealth: challenges and future directions for assessment, treatment, and dissemination. Health Psychol. 2015;34s:1205–1208. doi: 10.1037/hea0000323. [DOI] [PubMed] [Google Scholar]
- Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) 2017. Nationale VersorgungsLeitlinie Nicht-spezifischer Kreuzschmerz – Leitlinienreport, 2. Auflage. Version 1. [DOI] [Google Scholar]
- Chou R., Shekelle P. Will this patient develop persistent disabling low back pain? JAMA. 2010;303(13):1295–1302. doi: 10.1001/jama.2010.344. [DOI] [PubMed] [Google Scholar]
- Cohen J. Routledge; New York: 2013. Statistical power analysis for the behavioral sciences. [Google Scholar]
- Costa L., Maher C.G., McAuley J.H., Hancock M.J., Smeets R.J. Self-efficacy is more important than fear of movement in mediating the relationship between pain and disability in chronic low back pain. Eur. J. Pain (London, England) 2011;15(2):213–219. doi: 10.1016/j.ejpain.2010.06.014. [DOI] [PubMed] [Google Scholar]
- Costa L.D.C.M., Maher C.G., Hancock M.J., McAuley J.H., Herbert R.D., Costa L.O.P. The prognosis of acute and persistent low-back pain: a meta-analysis. CMAJ. 2012;184(11) doi: 10.1503/cmaj.111271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Costa N., Nielsen M., Jull G., et al. Low back pain websites do not meet the needs of consumers: a study of online resources at three time points. Health Inf. Manag. 2020;49(2–3):137–149. doi: 10.1177/1833358319857354. [DOI] [PubMed] [Google Scholar]
- Darlow B., Fullen B.M., Dean S., Hurley D.A., Baxter G.D., Dowell A. The association between health care professional attitudes and beliefs and the attitudes and beliefs, clinical management, and outcomes of patients with low back pain: a systematic review. Eur. J. Pain (London, England) 2012;16(1):3–17. doi: 10.1016/j.ejpain.2011.06.006. [DOI] [PubMed] [Google Scholar]
- Darmawan I., Bakker C., Brockman T.A., Patten C.A., Eder M. The role of social media in enhancing clinical trial recruitment: scoping review. J. Med. Internet Res. 2020;22(10) doi: 10.2196/22810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Deary V., Chalder T., Sharpe M. The cognitive behavioural model of medically unexplained symptoms: a theoretical and empirical review. Clin. Psychol. Rev. 2007;27(7):781–797. doi: 10.1016/j.cpr.2007.07.002. [DOI] [PubMed] [Google Scholar]
- Díaz-Arribas M.J., Fernández-Serrano M., Royuela A., Kovacs F.M., Gallego-Izquierdo T., Ramos-Sánchez M., Llorca-Palomera R., Pardo-Hervás P., Martín-Pariente O.S. Minimal clinically important difference in quality of life for patients with low back pain. Spine. 2017;42(24):1908–1916. doi: 10.1097/BRS.0000000000002298. [DOI] [PubMed] [Google Scholar]
- Dillmann U., Nilges P., Saile H., Gerbershagen H.U. Behinderungseinschätzung bei chronischen Schmerzpatienten [Assessing disability in chronic pain patients.] Schmerz (Berlin, Germany) 1994;8(2):100–110. doi: 10.1007/BF02530415. [DOI] [PubMed] [Google Scholar]
- DRKS. Deutsches Register Klinischer Studien (DRKS) [Available from: https://www.drks.de].
- Engers A., Jellema P., Wensing M., van der Windt D.A., Grol R., van Tulder M.W. Individual patient education for low back pain. Cochrane Database Syst. Rev. 2008;2008(1) doi: 10.1002/14651858.CD004057.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Faul F., Erdfelder E., Buchner A., Lang A.G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav. Res. Methods. 2009;41(4):1149–1160. doi: 10.3758/BRM.41.4.1149. [DOI] [PubMed] [Google Scholar]
- Gill S.C., Butterworth P., Rodgers B., Mackinnon A. Validity of the mental health component scale of the 12-item short-form health survey (MCS-12) as measure of common mental disorders in the general population. Psychiatry Res. 2007;152(1):63–71. doi: 10.1016/j.psychres.2006.11.005. [DOI] [PubMed] [Google Scholar]
- Gureje O. Classification of somatic syndromes in ICD-11. Curr. Opin. Psychiatry. 2015;28(5):345–349. doi: 10.1097/YCO.0000000000000186. [DOI] [PubMed] [Google Scholar]
- Harris P.A., Taylor R., Minor B.L., et al. The REDCap consortium: building an international community of software platform partners. J. Biomed. Inform. 2019;95 doi: 10.1016/j.jbi.2019.103208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henningsen P., Gündel H., Kop W.J., Löwe B., Martin A., Rief W., Rosmalen J., Schröder A., van der Feltz-Cornelis C., Van den Bergh O., on behalf of the EURONET-SOMA Group Persistent physical symptoms as perceptual dysregulation: a neuropsychobehavioral model and its clinical implications. Psychosom. Medicine. 2018;80(5):422–431. doi: 10.1097/PSY.0000000000000588. [DOI] [PubMed] [Google Scholar]
- Hollands G.J., Marteau T.M. The impact of using visual images of the body within a personalized health risk assessment: an experimental study. Br. J. Health Psychol. 2013;18(2):263–278. doi: 10.1111/bjhp.12016. [DOI] [PubMed] [Google Scholar]
- Hornung A.L., Rudisill S.S., Suleiman R.W., et al. Low back pain: what is the role of YouTube content in patient education? J. Orthop. Res. 2022;40(4):901–908. doi: 10.1002/jor.25104. [DOI] [PubMed] [Google Scholar]
- Hüsing P., Löwe B., Olde Hartman T.C., Frostholm L., Weigel A. Helpful explanatory models for somatoform symptoms (HERMES): study protocol of a randomised mixed-methods pilot trial. BMJ Open. 2021;11(3) doi: 10.1136/bmjopen-2020-044244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnson K.K., Bennett C., Rochani H. Significant improvement of somatic symptom disorder with brief psychoeducational intervention by PMHNP in primary care. J. Am. Psychiatric Nurs. Assoc. 2022;28(2):171–180. doi: 10.1177/1078390320960524. [DOI] [PubMed] [Google Scholar]
- Klaus K., Rief W., Brähler E., Martin A., Glaesmer H., Mewes R. The distinction between "medically unexplained" and "medically explained" in the context of somatoform disorders. Int. J. Behav. Med. 2013;20(2):161–171. doi: 10.1007/s12529-012-9245-2. [DOI] [PubMed] [Google Scholar]
- Kreuter M.W., Wray R.J. Tailored and targeted health communication: strategies for enhancing information relevance. Am. J. Health Behav. 2003;27(Suppl. 3):S227–S232. doi: 10.5993/ajhb.27.1.s3.6. [DOI] [PubMed] [Google Scholar]
- Kröner-Herwig B. In: Lehrbuch der Verhaltenstherapie, Band 2. Margraf J., Schneider S., editors. Springer; Berlin, Heidelberg: 2018. Chronischer Schmerz. [DOI] [Google Scholar]
- Lipsey M.W. Park Sage Publications; Newbury: 1990. Design sensitivity: statistical power for experimental research. [Google Scholar]
- Löwe B., Gräfe K., Zipfel S., Witte S., Loerch B., Herzog W. Diagnosing ICD-10 depressive episodes: superior criterion validity of the Patient Health Questionnaire. Psychother. Psychosom. 2004;73(6):386–390. doi: 10.1159/000080393. [DOI] [PubMed] [Google Scholar]
- Löwe B., Andresen V., Van den Bergh O., Huber T.B., von dem Knesebeck O., Lohse A.W., Nestoriuc Y., Schneider G., Schneider S.W., Schramm C., Ständer S., Vettorazzi E., Zapf A., Shedden-Mora M., Toussaint A. Persistent SOMAtic symptoms ACROSS diseases - from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211) BMJ Open. 2022;12(1) doi: 10.1136/bmjopen-2021-057596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lühnen J., Albrecht M., Hanßen K., Hildebrandt J., Steckelberg A. Leitlinie evidenzbasierte Gesundheitsinformation: Einblick in die Methodik der Entwicklung und Implementierung [Guideline for the Development of Evidence-based Patient Information: insights into the methods and implementation of evidence-based health information] Z. Evid. Fortbild. Qual. Gesundhwes. 2015;109(2):159–165. doi: 10.1016/j.zefq.2015.03.004. [DOI] [PubMed] [Google Scholar]
- Mangels M., Schwarz S., Sohr G., et al. Der Fragebogen zur Erfassung der schmerzspezifischen Selbstwirksamkeit (FESS) Diagnostica. 2009;55(2):84–93. doi: 10.1026/0012-1924.55.2.84. [DOI] [Google Scholar]
- Moher D., Hopewell S., Schulz K.F., Montori V., Gøtzsche P.C., Devereaux P.J., Elbourne D., Egger M., Altman D.G., CONSORT CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int. J. Surgery (London, England) 2012;10(1):28–55. doi: 10.1016/j.ijsu.2011.10.001. [DOI] [PubMed] [Google Scholar]
- National Guideline Centre (UK) National Institute for Health and Care Excellence (NICE); 2016. Low back pain and sciatica in over 16s: assessment and management. [PubMed] [Google Scholar]
- Nicholl B.I., Sandal L.F., Stochkendahl M.J., McCallum M., Suresh N., Vasseljen O., Hartvigsen J., Mork P.J., Kjaer P., Søgaard K., Mair F.S. Digital support interventions for the self-management of low back pain: a systematic review. J. Med. Internet Res. 2017;19(5) doi: 10.2196/jmir.7290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Connor S., Hanlon P., O'Donnell C.A., et al. Understanding factors affecting patient and public engagement and recruitment to digital health interventions: a systematic review of qualitative studies. BMC Med. Inform. Decis. Mak. 2016;16(1):120. doi: 10.1186/s12911-016-0359-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piontek K., Ketels G., Albrecht R., Schnurr U., Dybowski C., Brünahl C.A., Riegel B., Löwe B. Somatic and psychosocial determinants of symptom severity and quality of life in male and female patients with chronic pelvic pain syndrome. J. Psychosom. Res. 2019;120:1–7. doi: 10.1016/j.jpsychores.2019.02.010. [DOI] [PubMed] [Google Scholar]
- Relton C., Torgerson D., O'Cathain A., Nicholl J. Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design. BMJ (Clin. Res. Ed.) 2010;340 doi: 10.1136/bmj.c1066. [DOI] [PubMed] [Google Scholar]
- Rief W., Martin A. How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: a critical evaluation and a proposal for modifications. Annu. Rev. Clin. Psychol. 2014;10:339–367. doi: 10.1146/annurev-clinpsy-032813-153745. [DOI] [PubMed] [Google Scholar]
- Rief W., Burton C., Frostholm L., Henningsen P., Kleinstäuber M., Kop W.J., Löwe B., Martin A., Malt U., Rosmalen J., Schröder A., Shedden-Mora M., Toussaint A., van der Feltz-Cornelis C., on behalf of the EURONET-SOMA Group Core outcome domains for clinical trials on somatic symptom disorder, bodily distress disorder, and functional somatic syndromes: european network on somatic symptom disorders recommendations. Psychosom. Medicine. 2017;79(9):1008–1015. doi: 10.1097/PSY.0000000000000502. [DOI] [PubMed] [Google Scholar]
- Schiltenwolf M., Henningsen P., editors. Muskuloskelettale Schmerzen: Erkennen und Behandeln nach biopsychosozialem Konzept. Klett-Cotta; 2018. [Google Scholar]
- Sikorski F., König H.H., Wegscheider K., Zapf A., Löwe B., Kohlmann S. The efficacy of automated feedback after internet-based depression screening: study protocol of the German, three-armed, randomised controlled trial DISCOVER. Internet Interv. 2021;25 doi: 10.1016/j.invent.2021.100435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spitzer R.L., Kroenke K., Williams J.B., Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 2006;166(10):1092–1097. doi: 10.1001/archinte.166.10.1092. [DOI] [PubMed] [Google Scholar]
- Stevans J.M., Delitto A., Khoja S.S., Patterson C.G., Smith C.N., Schneider M.J., Freburger J.K., Greco C.M., Freel J.A., Sowa G.A., Wasan A.D., Brennan G.P., Hunter S.J., Minick K.I., Wegener S.T., Ephraim P.L., Friedman M., Beneciuk J.M., George S.Z., Saper R.B. Risk factors associated with transition from acute to chronic low back pain in US patients seeking primary care. JAMA Netw. Open. 2021;4(2) doi: 10.1001/jamanetworkopen.2020.37371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Toussaint A., Hüsing P., Kohlmann S., Löwe B. Detecting DSM-5 somatic symptom disorder: criterion validity of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8) in combination with the Somatic Symptom Disorder - B Criteria Scale (SSD-12) Psychol. Med. 2020;50(2):324–333. doi: 10.1017/S003329171900014X. [DOI] [PubMed] [Google Scholar]
- Vargas-Prada S., Coggon D. Psychological and psychosocial determinants of musculoskeletal pain and associated disability. Best Pract. Res. Clin. Rheumatol. 2015;29(3):374–390. doi: 10.1016/j.berh.2015.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- von der Lippe E., Krause L., Prost M., et al. Prävalenz von Rücken- und Nackenschmerzen in Deutschland. Ergebnisse der Krankheitslast-Studie BURDEN. 2020;2021(S3):1–14. doi: 10.25646/7854. [DOI] [Google Scholar]
- Vugts M.A.P., Joosen M.C.W., van der Geer J.E., et al. The effectiveness of various computer-based interventions for patients with chronic pain or functional somatic syndromes: a systematic review and meta-analysis. PLoS One. 2018;13(5) doi: 10.1371/journal.pone.0196467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waddell G., McCulloch J.A., Kummel E., Venner R.M. Nonorganic physical signs in low-back pain. Spine. 1980;5(2):117–125. doi: 10.1097/00007632-198003000-00005. [DOI] [PubMed] [Google Scholar]
- Ware J., Jr., Kosinski M., Keller S.D. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med. Care. 1996;34(3):220–233. doi: 10.1097/00005650-199603000-00003. [DOI] [PubMed] [Google Scholar]
- Woby S.R., Urmston M., Watson P.J. Self-efficacy mediates the relation between pain-related fear and outcome in chronic low back pain patients. Eur. J. Pain (London, England) 2007;11(7):711–718. doi: 10.1016/j.ejpain.2006.10.009. [DOI] [PubMed] [Google Scholar]
- World Health Organization . 2021. Musculoskeletal conditions.https://www.who.int/news-room/fact-sheets/detail/musculoskeletal-conditions Available from: [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data will be shared with researchers who provide a methodologically sound proposal; proposals should be directed to p.huesing@uke.de. To gain access, data requestors will need to sign a data access agreement. Data are available for 5 years at a third party website (https://data.mendeley.com/).


